Patients were about 40 percent less likely to survive the most severe heart attacks in the six coldest months of the year, according to research presented in June at the British Cardiovascular Society Conference.

On the heels of a deadlier-than-normal flu season, some scientists are wondering what will happen when a true pandemic hits. Vaccine doses would likely dry up—but cheap, readily available medications like statins could help a patient stave off flu as the virus runs its course, a pair of researchers told NPR.

Three pediatrics professors teamed up for an editorial in The New York Times imploring readers to lump juice into the unhealthy beverage category alongside soda.

Nonsteroidal anti-inflammatory drugs (NSAIDs) can be dangerous for patients with atrial fibrillation (AFib) when taken on top of oral anticoagulants, suggests a post hoc analysis of the RE-LY trial published in the Journal of the American College of Cardiology.

New ultra-thin drug-eluting stents (DES) are associated with a 16 percent reduction in target lesion failure (TLF) at one year compared to thicker-strut, second-generation DES, according to a meta-analysis published June 26 in Circulation.

School programs that provide fresh fruits and vegetables and limit the availability of sugar-sweetened beverages (SSBs) could prevent an estimated 22,383 deaths due to cardiometabolic disease each year in the U.S., researchers calculated in a study published July 6 in PLOS One.

About two-thirds of patients older than 65 who experience a myocardial infarction die within eight years, according to a new study—and nearly half die in that timeframe even if they receive percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) surgery.

In a study of nearly 25,000 children, those whose mothers adhered to five healthy lifestyle factors carried a 75 percent lower risk of obesity than children whose mothers had none of those habits.